2.Endoscope therapy of bleeding in portal hypertension.
Chinese Journal of Surgery 2008;46(22):1696-1698
3.Analysis of solitary rectal ulcer syndrome in 7 children.
Li Ya XIONG ; Lan Lan GENG ; Pei Yu CHEN ; Lu REN ; Hui Wen LI ; Jing XIE ; Pei Qun WU ; Si Tang GONG
Chinese Journal of Pediatrics 2022;60(9):920-924
Objective: To analyze the clinical features, treatment and prognosis of solitary rectal ulcer syndrome (SRUS) in children. Methods: The clinical data of 7 children who were diagnosed with SRUS in Department of Gastroenterology in Guangzhou Women and Children' Medical Center from January 2019 to December 2021 were retrospectively analyzed. The clinical data including general demographics, clinical presentations, endoscopic and histologic features, treatment and outcome were extracted from hospital medical records. Results: The 7 patients were all males, and the age of onset was 6-12 years. The course before diagnosis was 2-36 months. The most common symptom was rectal bleeding (6 cases) and most common findings at initial colonoscopy were ulcer in 3 cases and protuberance in 4 cases, both located only in rectum. The intestinal histopathology of 5 cases showed characteristic fibromuscular obliteration of lamina propria. Five children were treated with mesalamine granules or suppositories, and 2 cases underwent local excision. The follow-up lasted for 5-24 months and found symptoms relieved in 5 cases, improved in 1 case, and no remission in 1 case. Colonoscopy after the treatment was performed in 5 children, among whom 2 cases achieved mucosal healing. Conclusions: SRUS in children is mainly presented with rectal bleeding, and has characteristic histological change of ulcer and protuberance in endoscopy. Pathology is crucial for diagnosis and differential diagnosis. Both the medical and surgical treatment are effective for SRUS.
Child
;
Colonoscopy
;
Female
;
Gastrointestinal Hemorrhage/therapy*
;
Humans
;
Male
;
Rectal Diseases/therapy*
;
Rectum/surgery*
;
Retrospective Studies
;
Ulcer/therapy*
4.Clinical efficacy of tissue adhesive on intractable bleeding during endoscopic submucosal dissection.
Lili MA ; Jingjing LIAN ; Pinghong ZHOU ; Meidong XU ; Liqing YAO ; Shiyao CHEN
Chinese Journal of Gastrointestinal Surgery 2014;17(3):272-274
OBJECTIVETo investigate the efficacy of tissue adhesive on intractable bleeding during endoscopic submucosal dissection(ESD) and delayed bleeding.
METHODSA total of 9874 patients with gastrointestinal mucosal or submucosal tumors underwent ESD in our center from September 2006 to August 2013 and intractable bleeding occurred during ESD in 5 cases. Under the condition of no effective hemostasis methods, the tissue adhesive injection or spray were used to stop the bleeding. The efficacy and safety were evaluated.
RESULTSAll the 5 cases were successfully managed by the hemostasis method with tissue adhesive without any adverse event. In follow-up of two months after operation, wound healing and scar formation were observed under endoscopy.
CONCLUSIONTissue adhesive is safe, effective and fast for intractable bleeding during ESD and delayed bleeding.
Dissection ; Endoscopy, Gastrointestinal ; Gastric Mucosa ; surgery ; Hemorrhage ; etiology ; therapy ; Humans ; Intestinal Mucosa ; surgery ; Tissue Adhesives ; therapeutic use ; Treatment Outcome
5.Management of variceal hemorrhage: current status.
Chinese Medical Journal 2009;122(7):763-765
6.Guidelines of Treatment for Bleeding Peptic Ulcer Disease.
Il Kwun CHUNG ; Dong Ho LEE ; Heung Up KIM ; In Kyung SUNG ; Jin Ho KIM
The Korean Journal of Gastroenterology 2009;54(5):298-308
Peptic ulcer (PU) bleeding is the main cause of non-variceal gastrointestinal bleeding. Negative outcomes include re-bleeding and death, and many of the deaths are associated with decompensation of coexisting medical conditions precipitated by acute bleeding event. Accurate analysis of risk for clinical features can help physician to decide treatment modality. Endoscopy can detect bleeding stigmata and perform therapeutic hemostasis. Proton pump inhibitor (PPI) compared with placebo or H2RA reduces mortality following PU bleeding among patients with high-risk endoscopic findings, and reduces re-bleeding rates and surgical intervention. PPI treatment initiated prior to endoscopy in upper gastrointestinal (UGI) bleeding significantly reduces the proportion of patients with stigmata of recent hemorrhage (SRH) at index endoscopy but does not reduce mortality, re-bleeding or the need for surgery. The strategy of giving oral PPI before and after endoscopy, with endoscopic hemostasis for those with major SRH, is likely to be the most cost-effective. The treatment of H. pyori infection was found to be more effective than anti-secretory therapy in preventing recurrent bleeding from PU. H. pyori eradication alone and eradication followed by misoprostol (with switch to PPI, if misoprostol is not tolerated) are the two most cost-effective strategies to prevent ulcer bleeding among H. pyori-infected NSAID users, although the data cannot exclude PPIs also being cost-effective treatment. This review focuses specifically on the current treatment of patients with acute bleeding from a peptic ulcer.
Anti-Ulcer Agents/therapeutic use
;
Endoscopy, Gastrointestinal
;
Gastrointestinal Hemorrhage/diagnosis
;
Helicobacter Infections/diagnosis/drug therapy
;
Helicobacter pylori
;
Hemostasis, Endoscopic
;
Humans
;
Misoprostol/therapeutic use
;
Peptic Ulcer/surgery/*therapy
;
Peptic Ulcer Hemorrhage/surgery/*therapy
;
Proton Pump Inhibitors/therapeutic use
7.Rebleeding after Initial Endoscopic Hemostasis in Peptic Ulcer Disease.
Mi Jin HONG ; Sun Young LEE ; Jeong Hwan KIM ; In Kyung SUNG ; Hyung Seok PARK ; Chan Sup SHIM ; Choon Jo JIN
Journal of Korean Medical Science 2014;29(10):1411-1415
Endoscopic hemostasis is the first-line treatment for upper gastrointestinal bleeding (UGIB). Although several factors are known to be risk factors for rebleeding, little is known about the use of antithrombotics. We tried to verify whether the use of antithrombotics affects rebleeding rate after a successful endoscopic hemostasis for peptic ulcer disease (PUD). UGIB patients who underwent successful endoscopic hemostasis were included. Rebleeding was diagnosed when the previously treated lesion bled again within 30 days of the initial episode. Of 522 UGIB patients with PUD, rebleeding occurred in 93 patients (17.8%). The rate of rebleeding was higher with aspirin medication (P=0.006) and after a long endoscopic hemostasis (P<0.001). Of all significant variables, procedure time longer than 13.5 min was related to the rate of rebleeding (OR, 2.899; 95% CI, 1.768-4.754; P<0.001) on the logistic regression analysis. The rate of rebleeding after endoscopic hemostasis for PUD is higher in the patients after a long endoscopic hemostasis. Endoscopic hemostasis longer than 13.5 min is related to rebleeding after a successful endoscopic hemostasis for PUD.
Antithrombins/*therapeutic use
;
Aspirin/adverse effects
;
Female
;
Gastrointestinal Hemorrhage/drug therapy/*surgery
;
Hemorrhage/*drug therapy
;
Hemostasis, Endoscopic/methods
;
Humans
;
Male
;
Middle Aged
;
Peptic Ulcer/*surgery
;
Recurrence
;
Upper Gastrointestinal Tract/pathology
8.Comparison of Terlipressin and Octreotide with Variceal Ligation for Controlling Acute Esophageal Variceal Bleeding: a Randomized Prospective Study.
Sung Bum CHO ; Kang Jin PARK ; Jung Soo LEE ; Wan Sik LEE ; Chang Hwan PARK ; Young Eun JOO ; Hyun Soo KIM ; Sung Kyu CHOI ; Jong Sun REW ; Sei Jong KIM
The Korean Journal of Hepatology 2006;12(3):385-393
BACKGROUND/AIMS: Terlipressin and octreotide had been used to control acute variceal bleeding and to prevent early rebleeding after endoscopic hemostasis. We compared the efficacy and safety of terlipressin and octreotide combined with endoscopic variceal ligation (EVL) for the treatment of acute esophageal variceal bleeding and we evaluated their clinical significance as related to rebleeding. METHODS: The eighty eight cirrhotic patients were randomized to the terlipressin group (n=43; 2 mg i.v. initially and 1 mg i.v. at every 4 hours for 3 days) or the octreotide group (n=45; continuous infusion of 25 microgram/h for 5 days) combined with EVL for the treatment of acute esophageal variceal bleeding. RESULTS: The initial hemostasis rates were 98% (42/43 cases) in the terlipressin group and 96% (43/45 cases) in the octreotide group. The 5-day and 42-day rebleeding rates were 12% (5/43 cases) and 28% (12/43 cases), respectively, in the terlipressin group and 9% (4/45 cases) and 24% (11/45 cases), respectively, in the octreotide group. No significant difference was demonstrated between the terlipressin and octreotide groups. The mortality at 42 days was similar in both group, but a high mortality rate (48%) was shown to be related to 42-day rebleeding. The risk factors related to 42-day rebleeding were Child-Pugh class C (aOR=30.2, 95% CI=7.7-117.9), ascites above grade II (aOR=6.6, 95% CI=2.2-19.2) and advanced hepatocellular carcinoma (aOR=4.6, 95% CI=1.1-18.9). CONCLUSIONS: Comparing terlipressin and octreotide combined with EVL showed them to be equally safe and effective therapeutic agents in patients with acute esophageal variceal bleeding. The high risk factors related to early rebleeding were poor liver function and advanced hepatocellular carcinoma.
Acute Disease
;
Aged
;
Esophageal and Gastric Varices/drug therapy/surgery/*therapy
;
Female
;
Gastrointestinal Hemorrhage/drug therapy/surgery/*therapy
;
Humans
;
Liver Cirrhosis/drug therapy/surgery/*therapy
;
Lysine Vasopressin/*analogs & derivatives/therapeutic use
;
Male
;
Middle Aged
;
Octreotide/*therapeutic use
;
Vasoconstrictor Agents/*therapeutic use
9.Successful Management of Periampullary Diverticular Bleeding with Hemoclipping Using Side-viewing Endoscope during Endoscopic Retrograde Cholangiopancreatography.
Bo Geun PARK ; Young Wook YOO ; Joon Cheol SONG ; Sung Hee GAM ; Mi Sung KIM ; Byeong Seong KO
The Korean Journal of Gastroenterology 2016;67(3):146-149
Periampullary diverticulum is commonly found during endoscopy and can occur at any age although its prevalence increases with age. Periampullary diverticular bleeding is a rare and difficult to diagnose during clinical practice because of its unique appearance and location. This often can lead to massive bleeding and interfere with adequate bleeding control. Endoscopic management on duodenal diverticular bleeding is limited compared to colonic diverticular bleeding due to lack of experience. Herein, we report a case of active bleeding from a periampullary diverticulum during bile duct stone extraction diagnosed by side-viewing endoscope and successfully controlled using hemoclips without any complications.
Aged
;
Ampulla of Vater/surgery
;
Cholangiopancreatography, Endoscopic Retrograde
;
Diverticulum/*diagnosis/surgery
;
Gastrointestinal Hemorrhage/etiology/*therapy
;
Humans
;
Male
;
Surgical Instruments
;
Tomography, X-Ray Computed
10.Sigmoid Colon Diverticular Bleeding in a 75-year-old Woman.
Jeoung Ho CHOI ; Young Sook PARK ; Chae Young LIM ; Jun Young JUNG ; Seong Hwan KIM ; Won Mi LEE ; Jun Kil HAN ; Yun Young JUNG
The Korean Journal of Gastroenterology 2009;53(2):111-115
Most common cause of brisk hematochezia is diverticular bleeding in Western countries. It occurs in 15% of patients with diverticulosis and one-third of them appear to be massive. Most of diverticulosis in Western countries occur in the left colon but the right colon is more common in Korea. Especially, the reports of diverticular bleeding on left colon are rare in Korea. We report a case presenting with multiple diverticuli complicated by recurrent massive bleeding restricted to the left colon. 75-year-old female was admitted due to hematochezia and dizziness. On past history, two years and two weeks ago respectively, she was treated of diverticular bleeding with and without diverticulitis. Hemoglobin level was 9.8 g/dL. On Colonoscopy, numerous diverticuli were seen at sigmoid colon upto splenic flexure which showed fresh blood clots in the lumen. We diagnosed her as recurrent massive diverticular bleeding on the sigmoid colon. She received elective laparoscopic left hemicolectomy.
Aged
;
Colonoscopy
;
Diagnosis, Differential
;
Diverticulosis, Colonic/complications/*diagnosis/surgery
;
Female
;
Gastrointestinal Hemorrhage/*diagnosis/etiology/therapy
;
Humans
;
Recurrence
;
Sigmoid Diseases/*diagnosis/etiology/therapy
;
Tomography, X-Ray Computed